Molecular Imaging of HER2 Expression in Breast Cancer Using Technetium-99m-labelled DARPin HE3-G3 (99mTc-HE3-G3)

Condition:   Primary Breast Cancer Intervention:   Diagnostic Test: SPECT Sponsors:   Tomsk National Research Medical Center of the Russian Academy of Sciences;   Institute of Bioorganic Chemistry, Russian Academy of Sciences;   Uppsala University Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials